President Trump’s science adviser called for a return to reproducible and transparent research to kickstart stalled ...

As HHMI pauses Hanna Gray fellowship applications, opportunities for young scientists shrink further, making them look ...

Some are criticizing Biden’s team for not testing him earlier for prostate cancer. But overtesting is a particular concern ...

The past month has been a disastrous chain of events for UnitedHealth Group — which up until recently was a beloved stock on ...

Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It ...

Health insurers continue to use algorithms to predict how long patients need intense care — and thus how much care is covered ...

Regeneron plans to buy 23andMe out of bankruptcy for $256 million, potentially bringing to a close the saga of the consumer ...

The FDA finally approved Novavax's Covid-19 vaccine, but placed restrictions on it that its two competitors in the U.S. do ...

The grant termination letters say there are no appeals. Yet dozens of appeals have succeeded as biomedical researchers lobby ...

House Republicans are advancing a budget reconciliation bill with $700 billion in Medicaid savings, but still undecided is what year work requirements would begin.

No longer will our medicines be gated through animals, but rather through entirely human systems — leading to breakthrough ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.